| Product Code: ETC13364791 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Peripheral Intervention Drug-Eluting Devices Market was valued at USD 1.72 Billion in 2024 and is expected to reach USD 2.63 Billion by 2031, growing at a compound annual growth rate of 7.10% during the forecast period (2025-2031).
The Global Peripheral Intervention Drug-Eluting Devices Market is witnessing significant growth due to the rising prevalence of peripheral artery diseases and the increasing adoption of minimally invasive procedures. These devices are designed to deliver drugs directly to the site of intervention, reducing the risk of restenosis and improving patient outcomes. Key players in the market are investing in research and development activities to introduce innovative drug-eluting devices with enhanced efficacy and safety profiles. The market is also driven by advancements in technology, such as bioresorbable coatings and drug-eluting stents. North America holds a significant market share, followed by Europe, Asia Pacific, and the rest of the world. The increasing geriatric population and the growing demand for minimally invasive treatments are expected to further drive market growth in the coming years.
The Global Peripheral Intervention Drug-Eluting Devices Market is witnessing significant growth due to the increasing prevalence of peripheral artery disease and the rising demand for minimally invasive procedures. Key trends in the market include advancements in drug-eluting technologies, such as bioabsorbable coatings and polymer-free drug delivery systems, which enhance the efficacy and safety of these devices. Additionally, the growing adoption of combination therapies involving drug-eluting devices and other treatment modalities is creating new opportunities for market expansion. Other factors driving market growth include a rising geriatric population, lifestyle changes leading to higher incidences of cardiovascular diseases, and improving healthcare infrastructure in emerging economies. Overall, the market is poised for continued growth, with innovations and strategic collaborations among key players expected to drive further advancements in peripheral intervention drug-eluting devices.
Key challenges faced in the Global Peripheral Intervention Drug-Eluting Devices Market include regulatory hurdles, pricing pressures, and competition from alternative treatment methods. Regulatory approvals can be time-consuming and costly, impacting product development timelines and market entry. Pricing pressures from healthcare payers and providers can limit market penetration, especially in cost-sensitive regions. Additionally, the market faces competition from non-drug-eluting devices and other minimally invasive procedures, leading to a fragmented market landscape. Adapting to evolving regulatory requirements, demonstrating cost-effectiveness, and differentiating products from competitors are critical for companies operating in this market to succeed and drive adoption of peripheral intervention drug-eluting devices.
The Global Peripheral Intervention Drug-Eluting Devices Market is primarily driven by the increasing prevalence of peripheral artery diseases (PAD) and the growing demand for minimally invasive procedures for their treatment. The rising adoption of drug-eluting devices in peripheral interventions due to their ability to reduce restenosis rates and improve patient outcomes is also a significant factor fueling market growth. Technological advancements in drug-eluting devices, such as the development of advanced coatings and drug delivery systems, are further propelling market expansion. Additionally, the aging population and lifestyle factors contributing to the higher incidence of PAD are driving the demand for these devices. Overall, the market is expected to continue growing as healthcare providers increasingly prefer drug-eluting devices for peripheral interventions over traditional treatment methods.
Government policies related to the Global Peripheral Intervention Drug-Eluting Devices Market primarily focus on regulatory approvals and monitoring of these devices to ensure safety and efficacy. Regulatory bodies such as the FDA in the United States and the European Medicines Agency (EMA) in Europe play a key role in evaluating and approving drug-eluting devices for peripheral interventions. These policies aim to protect patient safety, promote innovation in medical device technology, and ensure compliance with quality standards. Additionally, reimbursement policies and healthcare regulations also impact market dynamics by influencing market access and adoption rates of drug-eluting devices for peripheral interventions. Continued monitoring and updates to these policies are essential to support the growth and development of the market while ensuring patient safety and quality of care.
The Global Peripheral Intervention Drug-Eluting Devices Market is expected to witness significant growth in the coming years due to the rising prevalence of peripheral artery diseases, advancements in technology, and increasing adoption of minimally invasive procedures. The market is projected to be driven by factors such as aging populations, lifestyle changes leading to higher incidences of chronic diseases, and the growing demand for innovative treatment options. Additionally, factors like the expanding healthcare infrastructure in emerging economies and increasing investments in research and development activities are likely to contribute to the market`s growth. However, challenges such as stringent regulatory requirements and high costs associated with these devices may hinder market expansion to some extent. Overall, the Global Peripheral Intervention Drug-Eluting Devices Market is anticipated to expand steadily, offering opportunities for market players to introduce novel products and expand their presence globally.
In the global Peripheral Intervention Drug-Eluting Devices market, North America holds a significant market share due to the high prevalence of peripheral artery disease, well-established healthcare infrastructure, and increasing adoption of advanced medical technologies. Europe follows closely behind, driven by the presence of key market players, growing geriatric population, and rising incidences of cardiovascular diseases. In Asia, the market is witnessing rapid growth attributed to improving healthcare facilities, increasing healthcare expenditure, and a growing patient population. The Middle East and Africa region are also experiencing growth, supported by government initiatives to enhance healthcare services and rising awareness about peripheral artery diseases. Latin America is expected to show steady growth due to improving healthcare access and rising investments in healthcare infrastructure.
Global Peripheral Intervention Drug-Eluting Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Global Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.8 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Global Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Global Peripheral Intervention Drug-Eluting Devices Market, 2021 - 2031 |
6.1 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031 |
6.1.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031 |
6.1.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Biodegradable Stents, 2021 - 2031 |
6.1.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Polymer-Based Stents, 2021 - 2031 |
6.1.6 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031 |
6.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Sirolimus, 2021 - 2031 |
6.2.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Paclitaxel, 2021 - 2031 |
6.2.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Everolimus, 2021 - 2031 |
6.2.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Zotarolimus, 2021 - 2031 |
6.2.6 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Rapamycin, 2021 - 2031 |
6.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031 |
6.3.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031 |
6.3.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031 |
6.3.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Aneurysm Repair, 2021 - 2031 |
6.3.6 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Stenosis Treatment, 2021 - 2031 |
6.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Ambulatory Centers, 2021 - 2031 |
6.4.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.6 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Cardiac Care Centers, 2021 - 2031 |
6.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Nanocoating, 2021 - 2031 |
6.5.3 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Biodegradable Coating, 2021 - 2031 |
6.5.4 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Sustained Drug Release, 2021 - 2031 |
6.5.5 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031 |
6.5.6 Global Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031 |
7 North America Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
7.1 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
7.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
8.4 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
8.5 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
9 Asia Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
9.1 Asia Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
9.4 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
9.5 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
10 Africa Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
10.1 Africa Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
10.4 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
10.5 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
11 Europe Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
11.1 Europe Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
11.4 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
11.5 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
12 Middle East Peripheral Intervention Drug-Eluting Devices Market, Overview & Analysis |
12.1 Middle East Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
12.4 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
12.5 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
13 Global Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
14 Global Peripheral Intervention Drug-Eluting Devices Market - Export/Import By Countries Assessment |
15 Global Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
15.1 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
15.3 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
15.4 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
16 Global Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
16.1 Global Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here